As anti-inflammatory rescue therapies begin making their way to patients with asthma, new questions about implementation of this life-saving therapy are emerging, prompting more exciting research from scientists and clinicians. In the first part of this mini-series on anti-inflammatory rescue therapies, host Amy Attaway, MD, of Cleveland Clinic, discusses these questions and more with asthma expert Njira Lugogo, MD, of University of Michigan.

This episode of the ATS Breathe Easy podcast is supported in part by AstraZeneca.

Artificial intelligence is a tool that clinicians and researchers are implementing in their practices and research, but what about its use in teaching the newest generation of doctors? Richard M. Schwartzstein, MD, of Harvard Medical School, discusses using AI for diagnostic education and developing cases, how it can work as a physician-support tool, and more with host Eddie Qian, MD, of Vanderbilt University Medical Center.

We're taking a breather this August as we work on bringing you more great episodes of the ATS Breathe Easy podcast. But we're not going off the air - instead, we're bringing back some of our best episodes of the last season. See you in September for season two!

Amy Attaway, MD, hosts the latest ATS Breathe Easy episode with former ATS President Monica Kraft, MD, and Asthma and Allergy Network's Chief Research Officer, De De Gardner, DrPH, discuss the benefits and challenges of biologics for asthma. What factors guide selection of a specific biologic for asthma? When should a patient transition from one biologic to another? This episode of the ATS Breathe Easy podcast is supported in part by AstraZeneca.